About the tool
Purpose
This tool provides options for PERTs by matching a patient’s current therapy against equivalent UK licensed products. It also states the enzymatic constituents by product and individual dose.
Included recommendations
The tool includes recommendations for both children and adults.
Recommendations for children have been developed in close consultation with colleagues from the Neonatal and Paediatric Pharmacy Group; recommendations for adults are as published in the Pancreatic Society of Great Britain and Ireland position statement on the PERT shortage.
Use the tool
Select the options for your patient and their current therapy to see suggested alternatives.
Prescribing and ordering advice
Our main article summarises overall current advice on the prescribing and ordering of PERTs.
Prescribing and ordering available pancreatic enzyme replacement therapies
Update history
- Link to Position Statement from Pancreatic Society of Great Britain and Ireland updated to latest version. Includes information on unlicensed product, Pangrol.
- Link to NPPG website amended to include their position statement.
- Published